Stage III Colorectal Cancer: Laura's Survivor Story

Patient Info: Laura Behnke, Female | Stage III

As of June 2026, Laura reported no trace of rectal cancer after treatment, ileostomy reversal, and port removal, while continuing to manage bowel-function changes and survivorship effects.

The Patient StoryRead more →

Long-term complete response to targeted therapy for relapsed lung cancer with an EGFR mutation

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: EGFR mutation

Her three most recent scans showed a complete response, and nearly 4 years after relapse she remained free of tumor progression while continuing targeted therapy.

PubMed CentralRead more →

Stage III Breast Cancer: Andrea's Survivor Story

Patient Info: Andrea, Female, Under 40 | Stage III

Completed chemotherapy, mastectomy/reconstruction, and radiation for Stage IIB-to-Stage III breast cancer diagnosed during pregnancy, and later described survivorship, parenting, fatigue, relationship strain, and recovery after treatment.

The Patient StoryRead more →

Stage III Lung Cancer: Bonnie's Patient Story

Patient Info: Bonnie Ulrich, Female, 40s | Stage III

Biomarkers: CA-125 elevated during 2019 workup; no lung cancer driver biomarker reported

After surgery-only Stage I lung cancer and 13 years in remission, Bonnie was later diagnosed with Stage III lung cancer in 2019; the later treatment regimen is not reported.

The Patient StoryRead more →

Pierre Onda: The Caregiver & His Fight for Empathy

Patient Info: Heidi Onda, Female | Stage III

Heidi Onda was diagnosed with Stage III primary lung cancer, and the story focuses on Pierre Onda's caregiver experience and their creation of The White Ribbon Project rather than a detailed treatment course or final disease status.

The Patient StoryRead more →

Stage III HER2-Positive Breast Cancer: Genoa's Survivor Story

Patient Info: Genoa M., Female | Stage III

Biomarkers: HER2-positive; ER-positive

As of June 2026, Genoa had completed treatment for Stage III HER2-positive, ER-positive breast cancer with neoadjuvant Taxotere/carboplatin/trastuzumab, lumpectomy, and radiation, and was focused on survivorship and rebuilding life after treatment.

The Patient StoryRead more →

Stage III Colorectal Cancer: Haley's Survivor Story

Patient Info: Haley Pollack, Female, Under 40 | Stage III

Years into survivorship after Stage IIIC colon cancer treated with surgery, CAPOX chemotherapy, and a recurrence-prevention clinical trial; later continued trial follow-up and advocacy for parents with cancer.

The Patient StoryRead more →

Stage III Triple-Negative Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of June 2026, Stephanie described being a 10-year survivor after Stage III BRCA1-positive triple-negative breast cancer, with remission shown after chemotherapy and no recurrence described.

The Patient StoryRead more →

Stage III Colorectal Cancer: Shelley's Survivor Story

Patient Info: Shelley, Female, 40s | Stage III

Shelley completed colectomy and adjuvant chemotherapy for Stage IIIB colon cancer and was in survivorship/recovery with lingering treatment effects and follow-up needs; explicit NED status is not stated.

The Patient StoryRead more →

Stage III HR-Positive Invasive Lobular Carcinoma: Tina's Patient Story

Patient Info: Tina, Female, Under 40 | Stage III

Biomarkers: ER-positive

As of June 2026, Tina was in survivorship after double mastectomy, AC-T chemotherapy, radiation, and ongoing hormone therapy with daily tamoxifen and Zoladex every 3 months.

The Patient StoryRead more →

Stage III Colorectal Cancer: Joanna's Survivor Story

Patient Info: Joanna, Female | Stage III

As of June 2026, Joanna’s story emphasized survivorship after Stage III rectal cancer, with major themes of delayed diagnosis, fertility preservation, radiation/chemotherapy planning, and the emotional recovery that followed treatment.

The Patient StoryRead more →

Stage III Colorectal Cancer: Catherine's Patient Story

Patient Info: Catherine, Female | Stage III

Catherine had a complete pathological response after chemoradiation and surgery for Stage III rectal cancer, then continued adjuvant Xeloda/oxaliplatin while waiting for post-treatment scans before accepting an NED label.

The Patient StoryRead more →

Stage III Colorectal Cancer: Maria's Survivor Story

Patient Info: Maria, Female | Stage III

Maria’s PET scan came back clear after 7 months of chemotherapy, 7 weeks of radiation, and surgery for Stage IIIC rectal cancer, but she described herself as still under surveillance with blood tests every 6 months and not cancer-free until 5 years.

The Patient StoryRead more →

Stage III Non-Small Cell Lung Cancer: Heidi's Survivor Story

Patient Info: Heidi N., Female, 50s | Stage III

Biomarkers: No targetable mutation identified

As of June 2026, Heidi was featured as a lung cancer advocate after treatment for inoperable Stage IIIA NSCLC; scans through January 2021 had shown no evidence of disease.

The Patient StoryRead more →

Stage III Lung Cancer: Peter's Survivor Story

Patient Info: Peter, Male, 70+ | Stage III

As of May 2026, Peter said his left-lung mass had gone after radiotherapy with chemotherapy and that he had returned to normal activities.

YouTube (AR search)Read more →

Stage III Colorectal Cancer: Ben's Patient Story

Patient Info: Ben Schultz, Under 40 | Stage III

Ben achieved a complete response and, 6 years later, remained on watch-and-wait surveillance with regular scans.

Fight Colorectal CancerRead more →

Growing teratoma syndrome after ovarian germ cell tumor treatment: Case 2

Patient Info: Anonymized, Female, Under 40 | Stage III

Biomarkers: AFP and beta-hCG elevated

After surgery and completion of chemotherapy in January 2025, she was without disease and her tumor markers were normal.

PubMed CentralRead more →

Stage III Colorectal Cancer: Jeffrey's Survivor Story

Patient Info: Jeffrey, Male | Stage III

As of May 2026, Jeffrey reported no evidence of disease, while remaining careful about surveillance language and managing lasting neuropathy after treatment.

The Patient StoryRead more →

Stage III Colorectal Cancer: Kristen's Survivor Story

Patient Info: Kristen, Female | Stage III

Completed active treatment for Stage III colon cancer and entered survivorship while managing permanent chemotherapy-induced peripheral neuropathy and chronic pain.

The Patient StoryRead more →

Durable response after multiple treatments for ovarian clear cell cancer

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: HRD-positive; BRCA-negative; ARID1A mutation; PD-L1 CPS 30

She achieved a complete response, completed maintenance immunotherapy in May 2024, and continued anlotinib with normal follow-up imaging and tumor markers.

PubMed CentralRead more →

Stage III Non-Small Cell Lung Cancer: Susie's Survivor Story

Patient Info: Susie, Female | Stage III

As of May 2026, Susie described completed surgery, chemotherapy, and radiotherapy for Stage III non-small cell lung cancer and was advocating for smoke-free legislation; no NED status was stated.

Cancer Research UKRead more →

Stage III lung cancer treatment complicated by immune-related lung inflammation

Patient Info: Anonymized, Male, 60s | Stage III

Biomarkers: EGFR-negative; ALK-negative; ROS1-negative

Mediastinal lymph nodes later enlarged despite additional systemic treatment, prompting radiation and further therapy.

PubMed CentralRead more →

Stage III Colorectal Adenocarcinoma: Meagan's Survivor Story

Patient Info: Meagan, Female, Under 40 | Stage III

In remission after surgery and 6 months of FOLFOX for high-risk Stage IIIC sigmoid colon adenocarcinoma, with ongoing 6-month scan monitoring and survivorship challenges including scanxiety and neuropathy.

The Patient StoryRead more →

Stage IIIA lung adenocarcinoma: major pathological response after neoadjuvant immunochemotherapy, complicated by DILI/TEN

Patient Info: Anonymized, Male, 50s | Stage III

Biomarkers: No lung molecular biomarkers reported

At 23 months after thoracoscopic left upper lobectomy, he was clinically stable with no evidence of tumor recurrence; severe postoperative DILI/TEN had improved after stopping the offending drug and intensive supportive treatment.

PubMed CentralRead more →